Cognitive Impairment Assessment in Breast Cancer Survivors

Starting soon

Conditions studied: Cancer Related Cognitive Impairment, Breast Cancer Survivors

In brief

This study is a monocentric, observational, cross-sectional study with a case-control design, aimed at evaluating the construct validity, discriminative ability, and diagnostic accuracy of a second-level neuropsychological test battery for the detection of cancer-related cognitive impairment in breast cancer survivors.

Key facts

Study ID: NCT07582770
Run by: European Institute of Oncology
People needed: 200
Starts: 2026-05-01
Expected to finish: 2030-04-01
Last updated by the study team: 2026-05-13

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

Age between 18 and 65 years old
Patient with a previous documented diagnosis of non-metastatic breast cancer (only for breast cancer survivor gruop)
Patient has completed chemotherapy for at least 6 months and for a maximum of 36 months if planned (only for breast cancer survivor gruop)
Understanding of the Italian language and ability to give informed consent

You may not qualify if…

Presence of brain metastases or history of brain radiation therapy (only for breast cancer survivor gruop)
Patient with previous diagnosis of other malignant tumors in addition to breast cancer (only for breast cancer survivor gruop)
Patient with a previous diagnosis of malignant carcinomas (only for control gruop)
Patient with a history of brain damage with unresolved neurological consequences
Patient with previous or current serious neurological pathologies
Patient with severe psychiatric conditions
Patient with systemic pathologies that could interfere with cognitive abilities
Patient taking medications that have a strong cognitive impact and that have not been stabilized for at least 4 weeks prior to enrollment
Patient with visual or hearing impairments that are not properly corrected
Patient with any disability that might compromise the validity of cognitive tests

Where it is running

European Institute of Oncology — Milan, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.